AI drug discovery startup Chai Discovery raised a $130M Series B led by Oak HC/FT and General Catalyst at a $1.3B valuation, taking its total funding to $225M (Caroline Hyde/Bloomberg)

Caroline Hyde / Bloomberg:
AI drug discovery startup Chai Discovery raised a $130M Series B led by Oak HC/FT and General Catalyst at a $1.3B valuation, taking its total funding to $225M  —  Chai Discovery, an artificial intelligence drug-discovery company backed by OpenAI, has raised $130 million to build a “computer-aided design suite” for molecules.

Posted from: this blog via Microsoft Power Automate.

Daily Deals